Story perspectives

AbbVie to Invest $100 Billion in U.S. Operations

1/13/2026

33 5

Summary

Story summary

AbbVie, the Illinois-based biopharmaceutical company, announced plans to invest $100 billion in its United States operations over the next decade, focusing on research and development, capital investments, and manufacturing.
In exchange for tariff and pricing exemptions, AbbVie struck a deal with the Trump administration to lower Medicaid prices.
AbbVie also aims to expand direct-to-patient offerings through the government portal TrumpRx for certain medicines.

1 of 1

Story summary

AbbVie, the Illinois-based biopharmaceutical company, announced plans to invest $100 billion in its United States operations over the next decade, focusing on research and development, capital investments, and manufacturing.
In exchange for tariff and pricing exemptions, AbbVie struck a deal with the Trump administration to lower Medicaid prices.
AbbVie also aims to expand direct-to-patient offerings through the government portal TrumpRx for certain medicines.